What is TTRX's operating cash flow?

TTRX (TTRX) reported operating cash flow of -$1.63M in Q1 2026.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

TTRX TTRX Operating Cash Flow

Operating Cash Flow at other companies

Regeneron PharmaceuticalsREGN

$1.08B+3.2%

Bausch Health CompaniesBHC

$230M+9.0%

Journey Medical CorporationDERM

$2.91M+203%

PTH

Pelthos Therapeutics Inc.PTHS

-$13.13M-1,977%

Celldex TherapeuticsCLDX

-$65.59M-20.6%

Arcutis Biotherapeutics, Inc.ARQT

$2.24M+107%

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's operating cash flow?: TTRX (TTRX) reported operating cash flow of -$1.63M in Q1 2026.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.